Study Evaluating the Safety and Tolerability of ILV-094 in Subjects With Psoriasis - Contacts and Locations

Study Evaluating the Safety and Tolerability of ILV-094 in Subjects With Psoriasis

This study is not yet open for participant recruitment.

Study NCT00563524. Last updated on December 21, 2007. Information provided by Wyeth

Please refer to this study by its ClinicalTrials.gov identifier: NCT00563524

Contacts


Contact: Trial Manager		clintrialparticipation@wyeth.com

Locations


United States, Indiana

	Indianapolis, Indiana, United States, 46256

United States, Massachusetts

	Boston, Massachusetts, United States

United States, Missouri

	St. Louis, Missouri, United States, 63117

United States, New York

	New York, New York, United States, 10028

United States, Pennsylvania

	Duncansville, Pennsylvania, United States, 16635

United States, Texas

	Dallas, Texas, United States, 75246

Sponsors and Collaborators

Wyeth

Investigators


Study Director:	Medical Monitor	Wyeth